Neurocognitive Function in HIV-Infected Patients: Comparison of Two Methods to Define Impairment-Reference-Cited by-同舟云学术

Neurocognitive Function in HIV-Infected Patients: Comparison of Two Methods to Define Impairment

Published:2014-07-31 Issue:7 Volume:9 Page:e103498
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Arenas-Pinto Alejandro,Winston Alan,Stöhr Wolfgang,Day John,Wiggins Rebecca,Quah Say Pheng,Ainsworth Jonathan,Fleck Sue,Dunn David,Accoroni Alex,Paton Nicholas I.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. The prevalence and incidence of neurocognitive impairment in the HAART era;KR Robertson;AIDS,2007

2. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors;V Tozzi;J Acquir Immune Defic Syndr,2007

3. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence;M Gisslen;BMC Infect Dis,2011

4. Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction;C Torti;BMC Med,2011

5. Is It Time to Rethink How Neuropsychological Tests Are Used to Diagnose Mild Forms of HIV-Associated Neurocognitive Disorders? Impact of False-Positive Rates on Prevalence and Power;AC Meyer;Neuroepidemiology,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive Function and the Relationship With Health Literacy and Secondary Prevention in Patients With Acute Coronary Syndrome at Early Discharge;Journal of Cardiovascular Nursing;2021-10-27

2. Assessing HIV provider knowledge, screening practices, and training needs for HIV-associated neurocognitive disorders. A short report;AIDS Care;2020-03-05

3. Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients;Journal of Antimicrobial Chemotherapy;2016-09-21

4. Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial;Clinical Infectious Diseases;2016-05-03

5. Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa;JAIDS Journal of Acquired Immune Deficiency Syndromes;2016-04-15